2024-31464. Implementing Statutory Addition of Certain Per- and Polyfluoroalkyl Substances (PFAS) to Toxics Release Inventory (TRI) Beginning With Reporting Year 2025

Chemical name/CASRN *	Triggering action	Effective date
Ammonium perfluorodecanoate (PFDA NH4) (3108-42-7)	Final Toxicity Value (Ref. 1)	1/1/25
Sodium perfluorodecanoate (PFDA-Na) (3830-45-3)	Final Toxicity Value (Ref. 1)	1/1/25
Perfluoro-3-methoxypropanoic acid (377-73-1)	Final Toxicity Value (Ref. 2)	1/1/25
6:2 Fluorotelomer sulfonate acid (27619-97-2)	Final Toxicity Value (Ref. 3)	1/1/25
6:2 Fluorotelomer sulfonate anion (425670-75-3)	Final Toxicity Value (Ref. 3)	1/1/25
6:2 Fluorotelomer sulfonate potassium salt (59587-38-1)	Final Toxicity Value (Ref. 3)	1/1/25
6:2 Fluorotelomer sulfonate ammonium salt (59587-39-2)	Final Toxicity Value (Ref. 3)	1/1/25
6:2 Fluorotelomer sulfonate sodium salt (27619-94-9)	Final Toxicity Value (Ref. 3)	1/1/25
Acetic acid, [(γ-ω-perfluoro-C8-10-alkyl)thio] derivs., Bu esters (3030471-22-5)	CBI Declassification (Ref. 4)	1/1/25
* CASRN means Chemical Abstracts Service Registry Number.

Under FY2020 NDAA section 7321(e), EPA must review CBI claims before PFAS with identities subject to a claim of protection from disclosure under 5 U.S.C. 552(a) (pursuant to 5 U.S.C. 552(b)(4)) are added to the list. The substance with the CASRN 3030471-22-5 met the criteria under FY2020 NDAA section 7321(c)(1)(A)(iii) but was subject to a claim of protection from disclosure under 5 U.S.C. 552(b)(4) at that time ( i.e., when the FY2020 NDAA was enacted). This substance's identity was published on the non-confidential portion of the TSCA Inventory in 2024; therefore, pursuant to FY2020 NDAA section 7321(e) the chemical was added to the TRI list and is being codified in the CFR by this rulemaking.

As established by the FY2020 NDAA, the addition of these PFAS to the EPCRA section 313 list of reportable chemicals is effective January 1 of the calendar year following any of the dates identified in FY2020 NDAA section 7321(c)(1)(A). Accordingly, these nine PFAS are reportable beginning with the 2025 reporting year ( i.e., reports due by July 1, 2026), and EPA is issuing this final rule to amend the EPCRA section 313 list of reportable chemicals in 40 CFR 372.65 to include the nine non-CBI PFAS added pursuant to the FY2020 NDAA.

Note that pursuant to the rule, entitled “Changes to Reporting Requirements for Per- and Polyfluoroalkyl Substances and to Supplier Notifications for Chemicals of Special Concern; Community Right-to-Know Toxic Chemical Release Reporting; Final Rule” (88 FR 74360, October 31, 2023 (FRL-8741-04-OCSPP)), all PFAS added to TRI pursuant to FY2020 NDAA sections 7321(b) and (c), are designated as chemicals of special concern (40 CFR 372.28), which also applies to the nine PFAS identified in this rulemaking. Chemicals of special concern are excluded from the de minimis exemption, may not be reported on a Form A (Alternate Threshold Certification Statement), and have limits related to reporting requirements. For more information on the addition of PFAS to the list of chemicals of special concern, see 40 CFR 372.28.

III. Good Cause Exception

Section 553(b)(B) of the Administrative Procedure Act (APA), 5 U.S.C. 553(b)(B), provides that, when an agency for good cause finds that public notice and comment procedures are impracticable, unnecessary, or contrary to the public interest, the agency may issue a rule without providing notice and an opportunity for public comment. EPA has determined that there is good cause for making this rule final without prior proposal and opportunity for comment because such notice and opportunity for comment is unnecessary. This action is being taken to comply with a mandate in an Act of Congress, in which Congress identified actions that automatically add these chemicals to the TRI. Thus, EPA has no discretion as to the outcome of this rule, which aligns the regulations with the self-effectuating changes provided by the FY2020 NDAA.

IV. References

The following is a listing of the documents that are specifically referenced in this document. The docket includes these documents and other ( print page 575) information considered by EPA, including documents that are referenced within the documents that are included in the docket, even if the referenced document is not itself physically located in the docket. For assistance in locating these other documents, please consult the person listed under FOR FURTHER INFORMATION CONTACT .

1. EPA. IRIS Toxicological Review of Perfluorodecanoic Acid (PFDA) and Related Salts. U.S. Environmental Protection Agency, Washington, DC, EPA/635/R-24/172Fa. 2024.

2. EPA. EPA Transcriptomic Assessment Product (ETAP) for Perfluoro-3-Methoxypropanoic Acid. U.S. Environmental Protection Agency, Washington, DC, EPA/600/X-24/066. 2024.

3. EPA. ORD Human Health Toxicity Value for 6:2 Fluorotelomer Sulfonic Acid. U.S. Environmental Protection Agency, Washington, DC, EPA/600/R-24/315. 2024.

4. EPA. Non-CBI TSCA Inventory, May 2024.

V. Statutory and Executive Order Reviews

Additional information about these statutes and Executive orders can be found at https://www.epa.gov/​laws-regulations/​laws-and-executive-orders.

A. Executive Order 12866: Regulatory Planning and Review and 14094: Modernizing Regulatory Review

This action is not a significant regulatory action as defined in Executive Order 12866 (58 FR 51735, October 4, 1993), as amended by Executive Order 14094 (88 FR 21879, April 11, 2023), and was therefore not subject to a requirement for Executive Order 12866 review.

B. Paperwork Reduction Act (PRA)

This action does not impose any new information collection burden under the PRA, 44 U.S.C. 3501 et. seq. Burden is defined in 5 CFR 1320.3(b). The Office of Management and Budget (OMB) has previously approved the information collection activities contained in the existing regulations and assigned OMB control numbers 2070-0212 and 2050-0078.

Currently, the facilities subject to the reporting requirements under EPCRA section 313 and PPA section 6607 must use EPA Toxic Chemicals Release Inventory Form R (EPA Form 9350-1). The nine newly added PFAS are subject to the same reporting requirements as other chemicals of special concern and are excluded from certain burden-reduction reporting options ( i.e., the de minimis exemption and the option to use Form A, range reporting). The Form R must be completed if a facility manufactures, processes, or otherwise uses any listed chemical above threshold quantities and meets certain other criteria.

Respondents may designate the specific chemical identity of a substance as a trade secret pursuant to EPCRA section 322 (42 U.S.C. 11042) and 40 CFR part 350. OMB has approved the reporting and recordkeeping requirements related to Form R, supplier notification, and petitions under OMB Control No. 2070-0212 (EPA Information Collection Request (ICR) No. 2613.04) and those related to trade secret designations under OMB Control No. 2050-0078 (EPA ICR No. 1428.12).

An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. The OMB control numbers relevant to EPA's regulations in 40 CFR are listed in 40 CFR part 9 and displayed on the information collection instruments ( e.g., forms, instructions).

C. Regulatory Flexibility Act (RFA)

This action is not subject to the RFA, 5 U.S.C. 601 et seq. The RFA applies only to rules subject to notice and comment rulemaking requirements under the APA, 5 U.S.C. 553, or any other statute. As discussed in Unit III., this rule is not subject to notice and comment requirements because the Agency has invoked the APA “good cause” exception under 5 U.S.C. 553(b).

D. Unfunded Mandates Reform Act (UMRA)

This action does not contain any unfunded mandate of $100 million or more as described in UMRA, 2 U.S.C. 1531-1538, and does not significantly or uniquely affect small governments. The action imposes no enforceable duty on any State, local, or Tribal governments or the private sector.

E. Executive Order 13132: Federalism

This action does not have federalism implications, as specified in Executive Order 13132 (64 FR 43255, August 10, 1999), because it will not have substantial direct effects on states, on the relationship between the National Government and the States, or on the distribution of power and responsibilities among the various levels of government.

F. Executive Order 13175: Consultation and Coordination With Indian Tribal Governments

This action does not have Tribal implications, as specified in Executive Order 13175 (65 FR 67249, November 9, 2000) because it will not have substantial direct effects on Tribal governments, on the relationship between the Federal government and the Indian Tribes, or on the distribution of power and responsibilities between the Federal Government and Indian Tribes. It does not have substantial direct effects on Tribal governments because EPA does not anticipate that reporting of the PFAS added to the TRI list in this action will be conducted by Tribes, so this rulemaking is not expected to impose substantial direct compliance costs on Tribal governments.

G. Executive Order 13045: Protection of Children From Environmental Health Risks and Safety Risks

This action is not subject to Executive Order 13045 (62 FR 19885, April 23, 1997) because it does not concern an environmental health or safety risk. Since this action does not concern human health, EPA's 2021 Policy on Children's Health also does not apply.

Although this action does not concern an environmental health or safety risk, this reporting rule will aid in collecting information regarding PFAS. This rule will be of use in identifying releases of PFAS to which children may be exposed. EPA believes that the information obtained as a result of this action could also be used by the public, government agencies and others to identify potential problems, set priorities, and take appropriate steps to reduce any potential human health or environmental risks related to PFAS, including those that may disproportionately affect children.

H. Executive Order 13211: Actions Concerning Regulations That Significantly Affect Energy Supply, Distribution, or Use

This action is not a significant energy action as defined in Executive Order 13211 (66 FR 28355, May 22, 2001), because it is not likely to have a significant adverse effect on the supply, distribution or use of energy.

I. National Technology Transfer and Advancement Act (NTTAA)

This rulemaking does not involve technical standards. As such, NTTAA section 12(d), 15 U.S.C. 272, does not apply to this action. ( print page 576)

J. Executive Order 12898: Federal Actions To Address Environmental Justice in Minority Populations and Low-Income Populations and Executive Order 14096: Revitalizing Our Nation's Commitment to Environmental Justice for All

Executive Order 12898 (59 FR 7629, February 16, 1994) directs Federal agencies, to the greatest extent practicable and permitted by law, to make environmental justice a part of their mission by identifying and addressing, as appropriate, disproportionately high and adverse human health or environmental effects of their programs, policies, and activities on minority populations (people of color) and low-income populations.

EPA believes that this type of action does not concern human health or environmental conditions and therefore cannot be evaluated with respect to potentially disproportionate and adverse effects on communities with environmental justice concerns. This action involves additions to reporting requirements that will not affect the level of protection provided to human health or the environment.

Although this action does not concern human health or environmental conditions, EPA may identify and address environmental justice concerns through information collected under TRI. The information obtained as a result of this rulemaking will lead to a better understanding of PFAS releases, which can help inform and tailor future EPA actions regarding PFAS. For example, EPA may identify and address environmental justice concerns as a result of the new PFAS information collected under this rule. The action will also better inform communities living near facilities that report to TRI, by providing them with information about PFAS releases and waste management practices occurring in their communities. Overall, EPA believes that the information obtained as a result of this action could be used by the public (including people of color, low-income populations and/or indigenous peoples) to inform their behavior as it relates to potential exposure to PFAS and by government agencies and others to identify potential problems, set priorities, and take appropriate steps to reduce any potential human health or environmental risks from PFAS.

K. Congressional Review Act (CRA)

This action is subject to the CRA, 5 U.S.C. 801 et seq., and EPA will submit a rule report to each House of the Congress and to the Comptroller General of the United States. This action is not a “major rule” as defined by 5 U.S.C. 804(2).

List of Subjects in 40 CFR Part 372

Environmental protection, Community right-to-know, Reporting and recordkeeping requirements, Toxic chemicals.

Dated: December 26, 2024.

Michal Freedhoff,

Assistant Administrator, Office of Chemical Safety and Pollution Prevention.

Therefore, for the reasons stated in the preamble, EPA is amending 40 CFR part 372 as follows:

PART 372—TOXIC CHEMICAL RELEASE REPORTING: COMMUNITY RIGHT-TO-KNOW

1. The authority citation for part 372 continues to read as follows:

Authority: 42 U.S.C. 11023 and 11048.

2. Amend § 372.65 by:

a. In paragraph (d) in table 4, adding in alphabetical order entries for “Acetic acid, [(γ- ω-perfluoro-C8-10-alkyl)thio] derivs., Bu esters”; “Ammonium perfluorodecanoate (PFDA NH4)”; “6:2 Fluorotelomer sulfonate acid”; “6:2 Fluorotelomer sulfonate ammonium salt”; “6:2 Fluorotelomer sulfonate anion”; “6:2 Fluorotelomer sulfonate potassium salt”; “6:2 Fluorotelomer sulfonate sodium salt”; “Perfluoro-3-methoxypropanoic acid”; “Sodium perfluorodecanoate (PFDA-Na)”.

b. In paragraph (e) in table 5, adding in numerical order entries for “377-73-1”; “3108-42-7”; “3830-45-3”; “27619-94-9”; “27619-97-2”; “59587-38-1”; “59587-39-2”; “425670-75-3”; “3030471-22-5”.

The additions read as follows:

§ 372.65

Chemicals and chemical categories to which this part applies.

* * * * *

(d) * * *

Table 4 to Paragraph ( d )

Chemical name	CASRN 1	Effective date
*         *         *         *         *         *         *
Acetic acid, [(γ-ω-perfluoro-C8-10-alkyl)thio] derivs., Bu esters	3030471-22-5	1/1/25
*         *         *         *         *         *         *
Ammonium perfluorodecanoate (PFDA NH4)	3108-42-7	1/1/25
*         *         *         *         *         *         *
6:2 Fluorotelomer sulfonate acid	27619-97-2	1/1/25
6:2 Fluorotelomer sulfonate ammonium salt	59587-39-2	1/1/25
6:2 Fluorotelomer sulfonate anion	425670-75-3	1/1/25
6:2 Fluorotelomer sulfonate potassium salt	59587-38-1	1/1/25
6:2 Fluorotelomer sulfonate sodium salt	27619-94-9	1/1/25
*         *         *         *         *         *         *
Perfluoro-3-methoxypropanoic acid	377-73-1	1/1/25
*         *         *         *         *         *         *
Sodium perfluorodecanoate (PFDA-Na)	3830-45-3	1/1/25
*         *         *         *         *         *         *
1  CASRN means Chemical Abstracts Service Registry Number.

( print page 577)

(e) * * *

Table 5 to Paragraph ( e )

CASRN 1	Chemical name	Effective date
*         *         *         *         *         *         *
377-73-1	Perfluoro-3-methoxypropanoic acid	1/1/25
*         *         *         *         *         *         *
3108-42-7	Ammonium perfluorodecanoate (PFDA NH4)	1/1/25
*         *         *         *         *         *         *
3830-45-3	Sodium perfluorodecanoate (PFDA-Na)	1/1/25
*         *         *         *         *         *         *
27619-94-9	6:2 Fluorotelomer sulfonate sodium salt	1/1/25
*         *         *         *         *         *         *
27619-97-2	6:2 Fluorotelomer sulfonate acid	1/1/25
*         *         *         *         *         *         *
59587-38-1	6:2 Fluorotelomer sulfonate potassium salt	1/1/25
*         *         *         *         *         *         *
59587-39-2	6:2 Fluorotelomer sulfonate ammonium salt	1/1/25
*         *         *         *         *         *         *
425670-75-3	6:2 Fluorotelomer sulfonate anion	1/1/25
*         *         *         *         *         *         *
3030471-22-5	Acetic acid, [(γ-ω-perfluoro-C8-10-alkyl)thio] derivs., Bu esters	1/1/25
*         *         *         *         *         *         *
1  CASRN means Chemical Abstracts Service Registry Number.